Last updated on June 2017

Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors CNS Tumors or Lymphoma


Brief description of study

This research study is evaluating a novel drug called CUDC-907 as a possible treatment for resistant (refractory) pediatric solid tumors (including neuroblastoma), lymphoma, or brain tumors.

Detailed Study Description

This is a Phase I clinical trial. A Phase I clinical trial tests the safety of an investigational intervention and also tries to find the best dose of the investigational intervention to use for further studies. "Investigational" means that the intervention is being studied. The FDA (the U.S. Food and Drug Administration) has not approved CUDC-907 as a treatment option for any disease. This is the first time that CUDC-907 will be given to children. In this research study, the investigators are evaluating a new drug, CUDC-907, as a potential new treatment for children with solid tumors, lymphomas and brain tumors. CUDC-907 is an oral drug that blocks certain proteins in tumor cells. These proteins may be important in the growth of some cancers. Laboratory experiments and results from adult studies demonstrate that CUDC-907 may stop tumor growth and, in some cases, cause tumor cells to die. CUDC-907 has been tested in adults with cancer to find out about side effects and dosing in adults. The primary goal of this study is to evaluate side effects of CUDC-907 and find the best dose of CUDC-907 when used in children. Other goals of this study are to determine whether this drug may have benefits against the types of cancer seen in children and to measure the effects of CUDC-907 in the blood.

Clinical Study Identifier: NCT02909777

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Steven DuBois, MD, MS

Dana Farber Cancer Institute
Boston, MA United States
  Connect »

Elizabeth Fox, MD

Children's Hospital of Philadelphia
Philadelphia, PA United States
  Connect »

Jodi Muscal, MD

Texas Children's, Baylor College of Medicine
Houston, TX United States
  Connect »